Citadel Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-337,629
| Closed | -$31.4M | – | 15209 |
|
|
2021
Q4 | $31.4M | Sell |
337,629
-13,143
| -4% | -$866K | 0.01% | 1556 |
|
|
2021
Q3 | $20.9M | Buy |
350,772
+342,521
| +4,151% | +$20.2M | ﹤0.01% | 1940 |
|
|
2021
Q2 | $563K | Sell |
8,251
-248,473
| -97% | -$16.2M | ﹤0.01% | 9798 |
|
|
2021
Q1 | $17.8M | Buy |
256,724
+219,579
| +591% | +$16.9M | ﹤0.01% | 2118 |
|
|
2020
Q4 | $2.85M | Sell |
37,145
-76,448
| -67% | -$5.73M | ﹤0.01% | 4660 |
|
|
2020
Q3 | $8.5M | Sell |
113,593
-896,387
| -89% | -$59.8M | ﹤0.01% | 2485 |
|
|
2020
Q2 | $63.6M | Sell |
1,009,980
-233,015
| -19% | -$12.8M | 0.02% | 643 |
|
|
2020
Q1 | $52.2M | Buy |
1,242,995
+699,451
| +129% | +$32.1M | 0.02% | 621 |
|
|
2019
Q4 | $24.7M | Buy |
543,544
+64,065
| +13% | +$3.03M | 0.01% | 1298 |
|
|
2019
Q3 | $21.9M | Buy |
479,479
+72,528
| +18% | +$4.08M | 0.01% | 1387 |
|
|
2019
Q2 | $23.9M | Sell |
406,951
-323,358
| -44% | -$16.7M | 0.01% | 1265 |
|
|
2019
Q1 | $32.7M | Sell |
730,309
-92,074
| -11% | -$4.22M | 0.02% | 950 |
|
|
2018
Q4 | $32M | Buy |
822,383
+245,305
| +43% | +$9.63M | 0.02% | 883 |
|
|
2018
Q3 | $26.6M | Buy |
577,078
+135,519
| +31% | +$5.49M | 0.01% | 1164 |
|
|
2018
Q2 | $19.3M | Buy |
441,559
+156,722
| +55% | +$6.74M | 0.01% | 1350 |
|
|
2018
Q1 | $11.3M | Sell |
284,837
-646,432
| -69% | -$25.1M | 0.01% | 1601 |
|
|
2017
Q4 | $31.6M | Buy |
931,269
+261,645
| +39% | +$7.45M | 0.02% | 882 |
|
|
2017
Q3 | $17.1M | Buy |
669,624
+615,834
| +1,145% | +$14.1M | 0.01% | 1187 |
|
|
2017
Q2 | $907K | Buy |
53,790
+51,118
| +1,913% | +$701K | ﹤0.01% | 4229 |
|
|
2017
Q1 | $39K | Buy |
+2,672
| New | +$39.6K | ﹤0.01% | 7108 |
|
|
2016
Q4 | – | Sell |
-1,001
| Closed | -$15.5K | – | 8069 |
|
|
2016
Q3 | $18K | Buy |
+1,001
| New | +$16.6K | ﹤0.01% | 7087 |
|
|
2016
Q1 | – | Sell |
-28,668
| Closed | -$459K | – | 8388 |
|
|
2015
Q4 | $545K | Sell |
28,668
-50,526
| -64% | -$1.03M | ﹤0.01% | 4356 |
|
|
2015
Q3 | $1.51M | Buy |
79,194
+74,799
| +1,702% | +$2.54M | ﹤0.01% | 3287 |
|
|
2015
Q2 | $204K | Sell |
4,395
-19,422
| -82% | -$843K | ﹤0.01% | 6295 |
|
|
2015
Q1 | $1.04M | Sell |
23,817
-7,370
| -24% | -$343K | ﹤0.01% | 3873 |
|
|
2014
Q4 | $1.08M | Buy |
31,187
+18,067
| +138% | +$733K | ﹤0.01% | 3672 |
|
|
2014
Q3 | $550K | Buy |
13,120
+3,592
| +38% | +$160K | ﹤0.01% | 4490 |
|
|
2014
Q2 | $558K | Buy |
9,528
+849
| +10% | +$53.5K | ﹤0.01% | 4253 |
|
|
2014
Q1 | $547K | Sell |
8,679
-22,423
| -72% | -$1.49M | ﹤0.01% | 4234 |
|
|
2013
Q4 | $1.82M | Sell |
31,102
-6,476
| -17% | -$338K | ﹤0.01% | 2631 |
|
|
2013
Q3 | $1.98M | Sell |
37,578
-57,073
| -60% | -$3.83M | ﹤0.01% | 2421 |
|
|
2013
Q2 | $7.29M | Buy |
+94,651
| New | +$7.73M | 0.01% | 1266 |
|
Citadel Advisors's ARNA Position: Q1 2022 in Review
Citadel Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 337,629 shares — an estimated $31.4M sold.
Citadel Advisors first reported a position in ARNA in Q2 2013 and held it in 32 quarters. The position peaked at $63.6M in Q2 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Citadel Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Citadel Advisors sold 337,629 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $31.4M.
- Citadel Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 32 quarters.
- Citadel Advisors's Arena Pharmaceuticals Inc position peaked at $63.6M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.